Across TCGA pan-cancer cohorts, MT1DP RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MT1DP data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher MT1DP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MT1DP expression acts as an unfavorable survival marker, although some lineages such as MESO and SKCM show a favorable association.
UVM, MESO, and LGG are the cancer types where MT1DP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.